ID   CPNE7_RAT               Reviewed;         556 AA.
AC   H1UBN0;
DT   14-OCT-2015, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 1.
DT   02-OCT-2024, entry version 57.
DE   RecName: Full=Copine-7 {ECO:0000305};
DE   AltName: Full=Copine VII {ECO:0000250|UniProtKB:Q99829, ECO:0000312|RGD:1307466};
GN   Name=Cpne7 {ECO:0000312|RGD:1307466};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|EMBL:CAO00508.1};
RN   [1] {ECO:0000312|EMBL:CAO00508.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar {ECO:0000312|EMBL:CAO00508.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:CAO00508.1};
RA   Galic M., Kriz A., Vigot R., Reinhard J., Zhang Y.P., Bezakova G.,
RA   Bentzinger C.F., Cloetta D., Stebler M., Bettler B., Oertner T.G.,
RA   Ruegg M.A.;
RT   "Regulation of dendritic spine morphogenesis and synapse formation by
RT   Copine family members.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF ASP-33; ASP-35; ASP-93;
RP   ASP-104; ASP-168; ASP-174; ASP-230 AND ASP-232.
RX   PubMed=26175110; DOI=10.1111/febs.13370;
RA   Perestenko P., Watanabe M., Beusnard-Bee T., Guna P., McIlhinney J.;
RT   "The second C2-domain of copines -2, -6 and -7 is responsible for their
RT   calcium-dependent membrane association.";
RL   FEBS J. 282:3722-3736(2015).
CC   -!- FUNCTION: Calcium-dependent phospholipid-binding protein that may play
CC       a role in calcium-mediated intracellular processes.
CC       {ECO:0000250|UniProtKB:Q99829}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UBL6}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9UBL6}. Cell membrane
CC       {ECO:0000269|PubMed:26175110}. Note=Translocates to the cell membrane
CC       in a calcium-dependent manner. {ECO:0000269|PubMed:26175110}.
CC   -!- DOMAIN: The C2 domain 1 is not necessary for calcium-mediated
CC       translocation and association to the plasma membrane (PubMed:26175110).
CC       The C2 domain 2 is necessary for calcium-mediated translocation and
CC       association to the plasma membrane (PubMed:26175110).
CC       {ECO:0000269|PubMed:26175110}.
CC   -!- SIMILARITY: Belongs to the copine family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM747283; CAO00508.1; -; mRNA.
DR   EMBL; AC119635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006255836.1; XM_006255774.3.
DR   AlphaFoldDB; H1UBN0; -.
DR   SMR; H1UBN0; -.
DR   STRING; 10116.ENSRNOP00000068558; -.
DR   iPTMnet; H1UBN0; -.
DR   PhosphoSitePlus; H1UBN0; -.
DR   jPOST; H1UBN0; -.
DR   Ensembl; ENSRNOT00000077701.2; ENSRNOP00000068558.1; ENSRNOG00000015397.8.
DR   Ensembl; ENSRNOT00055035242; ENSRNOP00055028575; ENSRNOG00055020651.
DR   Ensembl; ENSRNOT00060032066; ENSRNOP00060026083; ENSRNOG00060018633.
DR   Ensembl; ENSRNOT00065031830; ENSRNOP00065025390; ENSRNOG00065018941.
DR   AGR; RGD:1307466; -.
DR   RGD; 1307466; Cpne7.
DR   GeneTree; ENSGT00940000160442; -.
DR   HOGENOM; CLU_020452_4_0_1; -.
DR   InParanoid; H1UBN0; -.
DR   OMA; CSIGTRD; -.
DR   OrthoDB; 672483at2759; -.
DR   Reactome; R-RNO-1483206; Glycerophospholipid biosynthesis.
DR   PRO; PR:H1UBN0; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000015397; Expressed in spleen and 19 other cell types or tissues.
DR   ExpressionAtlas; H1UBN0; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISO:RGD.
DR   CDD; cd04048; C2A_Copine; 1.
DR   CDD; cd04047; C2B_Copine; 1.
DR   CDD; cd01459; vWA_copine_like; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR037768; C2B_Copine.
DR   InterPro; IPR045052; Copine.
DR   InterPro; IPR010734; Copine_C.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10857; COPINE; 1.
DR   PANTHER; PTHR10857:SF6; COPINE-7; 1.
DR   Pfam; PF00168; C2; 2.
DR   Pfam; PF07002; Copine; 1.
DR   SMART; SM00239; C2; 2.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   SUPFAM; SSF53300; vWA-like; 1.
DR   PROSITE; PS50004; C2; 2.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Cytoplasm; Membrane; Metal-binding; Nucleus;
KW   Reference proteome; Repeat.
FT   CHAIN           1..556
FT                   /note="Copine-7"
FT                   /id="PRO_0000434561"
FT   DOMAIN          1..128
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          135..262
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          305..504
FT                   /note="VWFA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   REGION          536..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         168
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         168
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         174
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         230
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         230
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         238
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MUTAGEN         33
FT                   /note="D->N: Does not inhibit calcium-dependent
FT                   translocation to the cell membrane; when associated with N-
FT                   35; N-93 and N-104."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         35
FT                   /note="D->N: Does not inhibit calcium-dependent
FT                   translocation to the cell membrane; when associated with N-
FT                   33; N-93 and N-104."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         93
FT                   /note="D->N: Does not inhibit calcium-dependent
FT                   translocation to the cell membrane; when associated with N-
FT                   33; N-35 and N-104."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         104
FT                   /note="D->N: Does not inhibit calcium-dependent
FT                   translocation to the cell membrane; when associated with N-
FT                   33; N-35 and N-93."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         168
FT                   /note="D->N: Inhibits strongly calcium-dependent
FT                   translocation to the cell membrane. Inhibits strongly
FT                   calcium-dependent translocation to the cell membrane; when
FT                   associated with N-173. Leads to the constitutive (calcium-
FT                   independent) attachment to the cell membrane; when
FT                   associated with N-174; N-230 and N-232."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         174
FT                   /note="D->N: Inhibits strongly calcium-dependent
FT                   translocation to the cell membrane. Inhibits strongly
FT                   calcium-dependent translocation to the cell membrane; when
FT                   associated with N-167. Leads to the constitutive (calcium-
FT                   independent) attachment to the cell membrane; when
FT                   associated with N-167; N-230 and N-232."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         230
FT                   /note="D->N: Inhibits strongly calcium-dependent
FT                   translocation to the cell membrane; when associated with N-
FT                   231. Leads to the constitutive (calcium-independent)
FT                   attachment to the cell membrane; when associated with N-
FT                   167; N-174 and N-232."
FT                   /evidence="ECO:0000269|PubMed:26175110"
FT   MUTAGEN         232
FT                   /note="D->N: Does not inhibit calcium-dependent
FT                   translocation to the cell membrane. Inhibits strongly
FT                   calcium-dependent translocation to the cell membrane; when
FT                   associated with N-229. Leads to the constitutive (calcium-
FT                   independent) attachment to the cell membrane; when
FT                   associated with N-168; N-174 and N-230."
FT                   /evidence="ECO:0000269|PubMed:26175110"
SQ   SEQUENCE   556 AA;  61978 MW;  5CEB5CED22B6197A CRC64;
     MSGDSERTVA PGVVPAPCAS KVELRLSCRH LLDRDPLTKS DPSVVLLQQA QGQWLQVDRT
     EVVKSSLHPV FSKVFTMDYY FEEVQKLRFE VYDTHGPSGL SCQDDDFLGG MECTLGQIVA
     QKKMTRPLLL RFGRNAGKST ITVIAEDISG NNGYVELSFQ ARKLDDKDLF SKSDPFLELY
     RVNDDGSEQL VYRTEVVKNN LNPVWEPFKV SLNSLCSCEE TRPLKCLVWD YDSRGKHDFI
     GDFTTTFAEM QKAFEEEQAQ WDCVNAKYKQ KKRNYKNSGV VILADLKLHR VHSFLDYIMG
     GCQIHCTVAI DFTASNGDPR NSCSLHHINP YQPNEYLRAL VAVGEVCQDY DSDKRFSALG
     FGARIPPKYE VSHDFAINFN PEDDECEGIQ GVVEAYQNCL PRVQLYGPTN VAPIISKVAR
     MAAAEERTGE ASQYYILLIL TDGVVTDMSD TREAIVRASH LPMSVIIVGV GNADFTDMQI
     LDGDDGILRS PRGEPALRDI VQFVPFRELK NASPAALAKC VLAEVPKQVV EYYSHKDLPP
     RSLGGQTGEA GPSSAP
//
